Dr. Baile is an Georgia Research Alliance Eminent Scholar in Agricultural Biotechnology and Distinguished Professor at The University of Georgia. Dr. Baile has coordinated the Georgia Research Alliance's program in Agricultural Biotechnology at the University of Georgia. This program has dual goals of conducting leading-edge research and seeding start-up companies to commercialize animal and plant biotechnology in Georgia. In 2002 he won the UGA Lamar Dodd Award for recognition of "outstanding body of scholarly and creative activities in the sciences".

Dr. Baile has a distinguished career in academic and commercial spheres with over thirty-five years experience at Harvard University, The University of Pennsylvania, The University of Georgia, SmithKline Beecham, and Monsanto Company. He has participated in the founding of seven companies and is presently on the Board of Directors of Abeome, Inc., AgGlobalVision, Inc., Angionics, Inc., AptoTec, Inc., InsectiGen, Inc., MetaMorphix, Inc., Oncose, Inc., and rPeptide, LLC. He served as a member of the Board of Trustees of the Georgia Research Alliance to represent the other 50 GRA Eminent Scholars.

Dr. Baile has served as a consultant to more than twenty companies, including several in the top Fortune 50. As Chief Executive Officer and Chairman of the Board of AptoTec, Inc. and InsectiGen, Inc., Dr. Baile provides management for the research and development and commercialization programs and did the same formerly for ProLinia, Inc. and Oncose, Inc. In 2003 he was recognized for his entrepreneurial spirit and energy by the Georgia Biomedical Partnership which presented him with a Community Award for "putting UGA on the map as one of the most active biotech business incubation centers in the Southeast".

Dr. Baile is known internationally for his research on the control of feed intake and the regulation of energy balance in animals. His contributions to the literature on the relationships between growth, lactation and the control of feed intake include approximately 350 journal articles, 300 abstracts and presentations for scientific meetings and 17 patents. Prior to joining the University of Georgia, Dr. Baile was employed by the Monsanto Company in St. Louis, MO, where he was a Distinguished Fellow and Director of Research and Development, Animal Sciences Division. His department successfully developed an injectible bovine somatotropin with a two-week delivery system for dairy cows. He has been successful in directing drug research and development projects from the discovery stage to FDA approval and commercialization.

Dr. Baile received his B.S. degree in Agriculture and Business from Central Missouri State University in 1962 and his Ph.D. in Nutrition from the University of Missouri in 1964.